Age-related macular degeneration;Dégénérescence maculaire liée à l'âge

Presse Medicale

Volumn 31, Issue 27, 2002, Pages 1282-1287

  Soubrane, Gisèle ^a   Haddad, Walid Michel ^a   Coscas, Gabriel ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR;

ADULT; AGED; ARTICLE; BLINDNESS; CLINICAL FEATURE; HUMAN; IMAGE ANALYSIS; LASER COAGULATION; PALLIATIVE THERAPY; PATHOGENESIS; PHOTORECEPTOR; PHOTOTHERAPY; PREVALENCE; PROGNOSIS; RETINA MACULA AGE RELATED DEGENERATION;

AGED; AGING; ANGIOGENESIS INHIBITORS; BLINDNESS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LASER COAGULATION; MACULAR DEGENERATION; MIDDLE AGED; PALLIATIVE CARE; PHOTORECEPTORS; PROGNOSIS;

EID: 17144453751     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study
2. An international classification and grading system for age-related maculopathy and age-related macular degeneration
3. Age-related macular degeneration and blindness due to neovascular maculopatby
4. Senile macular degeneration. Review of epidemiologic features
5. The Framingham Eye Study monograph
6. Prevalence of age-related maculopathy. The Beaver Dam Eye Study
7. The prevalence of agerelated maculopathy. The visual impairement project
8. Senile macular changes in the Black African
9. Racial/ethnic differences in age-related maculopathy. Third national health and nutrition examination survey
10. Heredity and age-related macular degeneration: Observations in monozygotics twins
11. Sibling correlation and segregation analysis of age-related maculopathy: The Beaver Dam Eye Study
12. Age-related Bruch's membrane change: A clinical study of the relative rule heridity and environment
13. Is genetic predisposition an important factor in age-related macular disease?
14. The ε4 allele of the apolipoprotein E gene as a potential protective factor for exsudative age-related macular degeneration
15. Mutation of the Stargardt disease gene (ABCR) in age-realted macular degeneration
16. The ABCR gene: A major disease gene in macular and peripheral retinal degeneration with onset from early chifldhood to the elderly
17. Smoking and age-related maculopathy: The Blue Mountains Eye Study
18. A prospective study of cigarettes' smoking and risk of age-related macular degeneration in men
19. Smoking and age-related macular degeneration. The POLA Study
20. Senile macular degeneration: A case-control study
21. Case-control study of the risk factors for age-related macular degeneration
22. Risk factors for neovascular age-related macular degeneration
23. The relationship of cardiovascular disease and its risk factors to age related maculopathy. The Beaver Dam Eye Study
24. Exposure to sunlights and other risk factors for age-related macular degeneration
25. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study
26. Antioxydant status and neovascular age-related macular degeneration
27. Dietary carotenoids, vitamines A, C, and E, and advanced age-related macular degeneration
28. Are antioxidant or supplements protective for age-related macular degeneration?
29. Age-related macular degeneration and antioxydant status in the POLA study
30. Associations of antioxydant enzymes with cataract and age-related macular degeneration. The POLA Study
31. Ageing and degeneration in the macular region: A clinico-pathological study
32. Age-related macular degeneration. Histopatologic studies
33. Bruch's membrane changes with age
34. Macular diseases. Senile changes of the choriocapillaris of the posterior pole
35. Aging of the human photoreceptor mosaic. Evidence for selective vulnerability of rods in central retina
36. Indocyanine green angiography of drusen
37. Evolution of soft drusen in age-related macular degeneration
38. Evolution of geographic atrophy of the retinal pigment epithelium
39. Geographic atrophy of the retinal pigment epithelium
40. Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss
41. Scanning laser ophthalmoscopic analysis of the pattern of visual loss in age-related geographic atrophy of the macula
42. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization
43. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration
44. Drusen and disciform macular detachment and degeneration
45. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration
46. Occult subretinal new vessels in age-related macular degeneration: Natural history and early laser treatment
47. Photocoagulation des néovaisseauxsous-rétiniens dans la dégénérescence maculaire sénile par laser à argon. Résultats de l'étude randomisée de 60 cas
48. Treatment of senile disciform macular degeneration: A single-blind randomized trial by argon laser photocoagulation
49. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial
50. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration
51. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration
52. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials-TAP report 1
53. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. Verteporfin in photodynamic therapy report 2